MAP Pharma(美國)

MAP Pharmaceuticals

美國MAPPharmaceuticalswww.mappharma.com美國MAP制藥使用專有的吸入技術(shù)，以提高治療效果和成熟的商業(yè)吸引力，同時盡量減少藥物通過其已知的安全性，有效性和商業(yè)化的歷史資本化的風險。LEVADEX™治療成人急性偏頭痛MAPPharmaceuticalsusesproprietaryinhalationtechnologiestoenhancethether apeuticbenefitsandcommercialattractivenessofprovendrugswhileminimizingriskbycapitalizingontheirknownsafety,efficacyandcommercializationhistory.TheclinicaldevelopmentprogramsatMAPPharmaceuticalsincludeproprietaryproductcandidatesthataddresslargemarketopportunities.ThemostadvancedproductcandidateisLEVADEX™orallyinhaledmigrainetherapy.Ourtechnologiesenableustodevelopproprietarydrugcandidatesfordeliveryviatherespiratorytracttomoreeffectivelytreatbothlocalrespiratoryandsystemicallytreatablediseases.Wecreateinhalabledrugparticleswiththespecificphysicalandchemicalcharacteristicstofacilitateefficientpulmonarydelivery.Webelievethiswillresultinm